January 11th 2024
Variations and conditions included in existing state bills, however, limit the effectiveness of this approach.
Navigating Approved Pre-exposure Prophylaxis (PrEP) Options for HIV Prevention: The Expanding Role of Pharmacists as Patient Educators and Advocates (Pharmacy Technician Credi...
2.0 Credits / HIV/AIDS
View More
Navigating Approved Pre-exposure Prophylaxis (PrEP) Options for HIV Prevention: The Expanding Role of Pharmacists as Patient Educators and Advocates (Pharmacist Credit)
2.0 Credits / HIV/AIDS
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
US Pharmacopeia Providing Support to COVID-19 Vaccine, Antiviral Drug Developers
March 23rd 2020The US Pharmacopeia (USP) is providing free technical assistance to developers of antiviral drugs and vaccines that will support the public health response to the coronavirus disease 2019 (COVID-19) pandemic.
Read More
New Genes Controlling HIV Infection Discovered That Could Help Make Predictions About Pharmacy
March 4th 2020Scientists at the Gladstone Institutes have cataloged host proteins that physically bind to HIV proteins, which identify human proteins that the virus can use to infect cells and spread.
Read More
Colorado Aims to Let Pharmacists Write Own Prescriptions for HIV Prevention Drugs
March 3rd 2020The bill is intended to "prevent a health insurance carrier from requiring a covered person to undergo step therapy or to receive prior authorization before receiving HIV infection prevention drugs."
Read More
U=U Continues to Unite HIV Community, Dismantle Stigma Around the Epidemic
March 3rd 2020The Undectectable = Untransmittable (U=U) campaign started in early 2016 and has been sharing the message to dismantle the stigma surrounding HIV ever since. More than 970 community partners from 101 countries have come together to clear up the confusion about the science behind U=U.
Read More
First Clinical Trial to Test PrEP, Dapivirine Ring for Safety in Pregnant Women Begins
February 20th 2020The study, called DELIVER: A Phase 3b Safety Study of the Dapivirine Ring and PrEP in Pregnant Women, will complement an ongoing NIH-funded trial of PrEP in adolescents and young women during pregnancy and the first 6 months after birth.
Read More
Maternal, Child Health Clinics Found to be Effective Platform for PrEP Delivery
January 10th 2020Program allows women in sub-Saharan Africa who visited any of 16 different maternal-child health centers to receive a behavioral assessment designed to provide information about HIV risk, learn about PrEP, and obtain a prescription for PrEP, if desired.
Read More